Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 7Neoplasms 4Endometrial Neoplasms 4Breast Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Lung Neoplasms 2Hematologic Neoplasms 2Colorectal Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Skin Neoplasms 1Sarcoma 1Salivary Gland Neoplasms 1Recurrence 1Rectal Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoma 1Liver Neoplasms 1Glioma 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1

Interventions

pembrolizumab 5Cyclophosphamide 4Carboplatin 4Filgrastim 3fludarabine 2Thiotepa 2Temozolomide 2Riluzole 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Immunohistochemistry 2Drug Therapy 2Counseling 2Bupropion 2vofatamab 1utomilumab 1trastuzumab deruxtecan 1toripalimab 1tasquinimod 1sodium thiosulfate 1sargramostim 1saracatinib 1poly ICLC 1pertuzumab 1liposomal doxorubicin 1lenvatinib 1ixabepilone 1etoposide phosphate 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × pertuzumab × Gynecologic × Clear all
NCT05150691 2026-01-28

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

DualityBio Inc.

Phase 1/2 Recruiting
796 enrolled
BreastGastrointestinalGynecologicThoracic

Bile Duct Neoplasms, Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡